Kumaka Industries informs about outcome of board meeting

21 Jul 2021 Evaluate

Kumaka Industries has informed that the Board of Directors of the Company at its meeting held on 21st July, 2021, has approved following business: Approval to the standalone un-audited financial result for the Quarter ended 30th June, 2021 along with Limited Review Report is attached for reference and record, Approval to the Board’s Report and approval to the appointment of Nitil Kamble as an Independent Additional Director of the Company.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×